

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 7.89114481 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.89114481 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 7.36823692 |
| 4 | skeletal muscle contraction (GO:0003009) | 7.08765158 |
| 5 | muscle cell fate commitment (GO:0042693) | 6.94883311 |
| 6 | actin-mediated cell contraction (GO:0070252) | 6.68011072 |
| 7 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.19394381 |
| 8 | skeletal muscle fiber development (GO:0048741) | 5.82046927 |
| 9 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 5.44415228 |
| 10 | response to muscle activity (GO:0014850) | 5.38472796 |
| 11 | skeletal muscle adaptation (GO:0043501) | 5.23164311 |
| 12 | myotube cell development (GO:0014904) | 5.16034337 |
| 13 | skeletal muscle tissue regeneration (GO:0043403) | 5.06037006 |
| 14 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 5.00965674 |
| 15 | skeletal muscle tissue development (GO:0007519) | 5.00382748 |
| 16 | muscle cell cellular homeostasis (GO:0046716) | 4.96944192 |
| 17 | actin filament-based movement (GO:0030048) | 4.88086685 |
| 18 | creatine metabolic process (GO:0006600) | 4.85434891 |
| 19 | striated muscle contraction (GO:0006941) | 4.82525237 |
| 20 | negative regulation of inclusion body assembly (GO:0090084) | 4.73786435 |
| 21 | outer ear morphogenesis (GO:0042473) | 4.52844940 |
| 22 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.48018585 |
| 23 | chemosensory behavior (GO:0007635) | 4.47381942 |
| 24 | otic vesicle formation (GO:0030916) | 4.40225032 |
| 25 | pseudouridine synthesis (GO:0001522) | 4.38515086 |
| 26 | plasma membrane repair (GO:0001778) | 4.37373528 |
| 27 | neuromuscular synaptic transmission (GO:0007274) | 4.25184915 |
| 28 | regulation of relaxation of muscle (GO:1901077) | 4.24815445 |
| 29 | muscle atrophy (GO:0014889) | 4.20282069 |
| 30 | sarcomere organization (GO:0045214) | 4.20030789 |
| 31 | response to inactivity (GO:0014854) | 4.15465515 |
| 32 | myofibril assembly (GO:0030239) | 4.10954138 |
| 33 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.10500956 |
| 34 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.06542183 |
| 35 | striated muscle atrophy (GO:0014891) | 4.06104507 |
| 36 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.02605695 |
| 37 | muscle fiber development (GO:0048747) | 3.95056618 |
| 38 | regulation of mitotic spindle organization (GO:0060236) | 3.88822117 |
| 39 | muscle contraction (GO:0006936) | 3.86824115 |
| 40 | macroautophagy (GO:0016236) | 3.81775849 |
| 41 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.71378357 |
| 42 | muscle organ development (GO:0007517) | 3.70714578 |
| 43 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.70129264 |
| 44 | muscle structure development (GO:0061061) | 3.67190829 |
| 45 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.61597245 |
| 46 | muscle system process (GO:0003012) | 3.57007601 |
| 47 | positive regulation of microtubule polymerization (GO:0031116) | 3.53097302 |
| 48 | striated muscle adaptation (GO:0014888) | 3.40938837 |
| 49 | muscle organ morphogenesis (GO:0048644) | 3.35800794 |
| 50 | striated muscle tissue development (GO:0014706) | 3.34395239 |
| 51 | membrane depolarization during action potential (GO:0086010) | 3.32023938 |
| 52 | oligosaccharide catabolic process (GO:0009313) | 3.30955613 |
| 53 | neuronal action potential propagation (GO:0019227) | 3.21783321 |
| 54 | striated muscle cell development (GO:0055002) | 3.15843257 |
| 55 | peristalsis (GO:0030432) | 3.14371244 |
| 56 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.13775251 |
| 57 | cardiac muscle contraction (GO:0060048) | 3.12099238 |
| 58 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.10457957 |
| 59 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.10457957 |
| 60 | synaptic transmission, cholinergic (GO:0007271) | 3.08215327 |
| 61 | muscle tissue morphogenesis (GO:0060415) | 3.07961946 |
| 62 | muscle tissue development (GO:0060537) | 3.06739858 |
| 63 | neuron fate determination (GO:0048664) | 3.06242006 |
| 64 | glucan biosynthetic process (GO:0009250) | 3.04888242 |
| 65 | glycogen biosynthetic process (GO:0005978) | 3.04888242 |
| 66 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.04614669 |
| 67 | cell aggregation (GO:0098743) | 3.02341998 |
| 68 | cartilage condensation (GO:0001502) | 3.02341998 |
| 69 | cardiac myofibril assembly (GO:0055003) | 2.99820660 |
| 70 | actomyosin structure organization (GO:0031032) | 2.99709709 |
| 71 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 2.98638405 |
| 72 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.98270301 |
| 73 | regulation of cell communication by electrical coupling (GO:0010649) | 2.95571452 |
| 74 | snRNA transcription (GO:0009301) | 2.93912185 |
| 75 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.92402303 |
| 76 | postsynaptic membrane organization (GO:0001941) | 2.92110594 |
| 77 | negative regulation of protein localization to cell surface (GO:2000009) | 2.91792284 |
| 78 | neuronal action potential (GO:0019228) | 2.91384353 |
| 79 | cardiac muscle cell development (GO:0055013) | 2.82178688 |
| 80 | muscle adaptation (GO:0043500) | 2.80633440 |
| 81 | calcium ion import (GO:0070509) | 2.80360301 |
| 82 | cochlea morphogenesis (GO:0090103) | 2.78677759 |
| 83 | cell wall macromolecule catabolic process (GO:0016998) | 2.78155529 |
| 84 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.77575931 |
| 85 | lateral sprouting from an epithelium (GO:0060601) | 2.77355097 |
| 86 | muscle cell development (GO:0055001) | 2.76997023 |
| 87 | positive regulation of cation channel activity (GO:2001259) | 2.76551749 |
| 88 | notochord development (GO:0030903) | 2.74119049 |
| 89 | response to activity (GO:0014823) | 2.73204437 |
| 90 | regulation of striated muscle contraction (GO:0006942) | 2.71688591 |
| 91 | myoblast fusion (GO:0007520) | 2.69802862 |
| 92 | regulation of actin filament-based movement (GO:1903115) | 2.69524943 |
| 93 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.69256128 |
| 94 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.68775688 |
| 95 | nephron tubule formation (GO:0072079) | 2.68579910 |
| 96 | regulation of spindle organization (GO:0090224) | 2.68503371 |
| 97 | glycogen catabolic process (GO:0005980) | 2.68148077 |
| 98 | myotube differentiation (GO:0014902) | 2.67887422 |
| 99 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.65249304 |
| 100 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.64380983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.42159291 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.25881910 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.96118110 |
| 4 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.95923765 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.47231315 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.45811239 |
| 7 | FUS_26573619_Chip-Seq_HEK293_Human | 2.30073559 |
| 8 | RXR_22108803_ChIP-Seq_LS180_Human | 2.26580014 |
| 9 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.25185623 |
| 10 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.20969725 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.15804301 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08538952 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07244858 |
| 14 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.04776643 |
| 15 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00743202 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.97352856 |
| 17 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.91938600 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.88853901 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86367980 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70348779 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 1.68615370 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64533405 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56157379 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53270573 |
| 25 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.46190855 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.45745489 |
| 27 | CJUN_26792858_Chip-Seq_BT549_Human | 1.41787973 |
| 28 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41412867 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40739774 |
| 30 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40625526 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39909694 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39286192 |
| 33 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.38818942 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35688854 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.34174522 |
| 36 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.34017554 |
| 37 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32203494 |
| 38 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.30059374 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28922761 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.28666295 |
| 41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.27394011 |
| 42 | TBL1_22424771_ChIP-Seq_293T_Human | 1.26842690 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26270201 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24725974 |
| 45 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24455892 |
| 46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.24100485 |
| 47 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23809028 |
| 48 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23809028 |
| 49 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23534217 |
| 50 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.22992523 |
| 51 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.21377501 |
| 52 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20685860 |
| 53 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.19421908 |
| 54 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18122930 |
| 55 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18086307 |
| 56 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17472170 |
| 57 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17425395 |
| 58 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17425395 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17365733 |
| 60 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.16995872 |
| 61 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16494969 |
| 62 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.16462411 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16391009 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16391009 |
| 65 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.15944224 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15385026 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13968751 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13062824 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13057491 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12975961 |
| 71 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.11479332 |
| 72 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.10962901 |
| 73 | * MYC_19829295_ChIP-Seq_ESCs_Human | 1.10741506 |
| 74 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.10675152 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10461534 |
| 76 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.10332805 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09469583 |
| 78 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.09197918 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08073457 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07848955 |
| 81 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07785757 |
| 82 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07358696 |
| 83 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06388167 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04316215 |
| 85 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03814273 |
| 86 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.03785556 |
| 87 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03263309 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03083923 |
| 89 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01988885 |
| 90 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01901523 |
| 91 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.01524035 |
| 92 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.00861265 |
| 93 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00388345 |
| 94 | NFYB_21822215_ChIP-Seq_K562_Human | 1.00085120 |
| 95 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.99944432 |
| 96 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99485038 |
| 97 | CBP_21632823_ChIP-Seq_H3396_Human | 0.99343302 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99294415 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98350645 |
| 100 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.98029801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.03974100 |
| 2 | MP0000749_muscle_degeneration | 5.33656926 |
| 3 | MP0005451_abnormal_body_composition | 5.18258677 |
| 4 | MP0003646_muscle_fatigue | 4.68603830 |
| 5 | MP0000751_myopathy | 4.11277269 |
| 6 | MP0000750_abnormal_muscle_regeneration | 3.39834958 |
| 7 | MP0002106_abnormal_muscle_physiology | 3.33298748 |
| 8 | MP0000569_abnormal_digit_pigmentation | 3.12739945 |
| 9 | MP0004036_abnormal_muscle_relaxation | 2.93595586 |
| 10 | MP0005369_muscle_phenotype | 2.84925739 |
| 11 | MP0000759_abnormal_skeletal_muscle | 2.61007926 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.60503161 |
| 13 | MP0002234_abnormal_pharynx_morphology | 2.59287181 |
| 14 | MP0002108_abnormal_muscle_morphology | 2.57881431 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.54321824 |
| 16 | MP0000747_muscle_weakness | 2.51160315 |
| 17 | MP0002269_muscular_atrophy | 2.47777425 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.33744378 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.28934571 |
| 20 | MP0000733_abnormal_muscle_development | 2.15906208 |
| 21 | MP0000013_abnormal_adipose_tissue | 1.90097748 |
| 22 | MP0004270_analgesia | 1.80821011 |
| 23 | MP0002332_abnormal_exercise_endurance | 1.74319560 |
| 24 | MP0006072_abnormal_retinal_apoptosis | 1.66209699 |
| 25 | MP0004084_abnormal_cardiac_muscle | 1.59131279 |
| 26 | MP0005083_abnormal_biliary_tract | 1.55443276 |
| 27 | MP0002972_abnormal_cardiac_muscle | 1.54603866 |
| 28 | MP0005330_cardiomyopathy | 1.51742336 |
| 29 | MP0003045_fibrosis | 1.48294157 |
| 30 | MP0002282_abnormal_trachea_morphology | 1.45168170 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.44593177 |
| 32 | MP0009384_cardiac_valve_regurgitation | 1.43079886 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.36262219 |
| 34 | MP0004130_abnormal_muscle_cell | 1.31943751 |
| 35 | MP0002971_abnormal_brown_adipose | 1.29545436 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.28976216 |
| 37 | MP0004233_abnormal_muscle_weight | 1.26645715 |
| 38 | MP0003137_abnormal_impulse_conducting | 1.23104641 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.21328204 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.20851016 |
| 41 | MP0005253_abnormal_eye_physiology | 1.20123274 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.16285272 |
| 43 | MP0004142_abnormal_muscle_tone | 1.09732109 |
| 44 | MP0009046_muscle_twitch | 1.09386936 |
| 45 | MP0000762_abnormal_tongue_morphology | 1.08201512 |
| 46 | MP0003959_abnormal_lean_body | 1.05624325 |
| 47 | MP0003567_abnormal_fetal_cardiomyocyte | 1.05486290 |
| 48 | MP0010630_abnormal_cardiac_muscle | 1.01309596 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.01272166 |
| 50 | MP0005360_urolithiasis | 1.01220867 |
| 51 | MP0001661_extended_life_span | 0.99286636 |
| 52 | MP0005174_abnormal_tail_pigmentation | 0.98904887 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 0.96456070 |
| 54 | MP0005385_cardiovascular_system_phenoty | 0.94870001 |
| 55 | MP0001544_abnormal_cardiovascular_syste | 0.94870001 |
| 56 | MP0009250_abnormal_appendicular_skeleto | 0.94350361 |
| 57 | MP0004885_abnormal_endolymph | 0.90336505 |
| 58 | MP0003828_pulmonary_edema | 0.86494686 |
| 59 | MP0005423_abnormal_somatic_nervous | 0.86153829 |
| 60 | MP0000049_abnormal_middle_ear | 0.85355261 |
| 61 | MP0001299_abnormal_eye_distance/ | 0.85156837 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 0.84586636 |
| 63 | MP0008775_abnormal_heart_ventricle | 0.84536160 |
| 64 | MP0003329_amyloid_beta_deposits | 0.82913366 |
| 65 | MP0006138_congestive_heart_failure | 0.81294978 |
| 66 | MP0001984_abnormal_olfaction | 0.79774489 |
| 67 | MP0001963_abnormal_hearing_physiology | 0.78412920 |
| 68 | MP0002932_abnormal_joint_morphology | 0.78292234 |
| 69 | MP0002127_abnormal_cardiovascular_syste | 0.78134298 |
| 70 | MP0005266_abnormal_metabolism | 0.77670116 |
| 71 | MP0008569_lethality_at_weaning | 0.72823870 |
| 72 | MP0005332_abnormal_amino_acid | 0.72265863 |
| 73 | MP0002067_abnormal_sensory_capabilities | 0.68811129 |
| 74 | MP0002822_catalepsy | 0.68532678 |
| 75 | MP0002114_abnormal_axial_skeleton | 0.68332589 |
| 76 | MP0004510_myositis | 0.68091111 |
| 77 | MP0002272_abnormal_nervous_system | 0.67401169 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67056413 |
| 79 | MP0002249_abnormal_larynx_morphology | 0.65240666 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 0.64624184 |
| 81 | MP0000534_abnormal_ureter_morphology | 0.64235864 |
| 82 | MP0004484_altered_response_of | 0.61766903 |
| 83 | MP0001968_abnormal_touch/_nociception | 0.57982132 |
| 84 | MP0005670_abnormal_white_adipose | 0.57492145 |
| 85 | MP0010368_abnormal_lymphatic_system | 0.57412670 |
| 86 | MP0000955_abnormal_spinal_cord | 0.57212154 |
| 87 | MP0002229_neurodegeneration | 0.56283632 |
| 88 | MP0003879_abnormal_hair_cell | 0.55522017 |
| 89 | MP0005452_abnormal_adipose_tissue | 0.55114394 |
| 90 | MP0004742_abnormal_vestibular_system | 0.53597583 |
| 91 | MP0000372_irregular_coat_pigmentation | 0.53392433 |
| 92 | MP0004134_abnormal_chest_morphology | 0.52908669 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.52145005 |
| 94 | MP0000538_abnormal_urinary_bladder | 0.51595762 |
| 95 | MP0000026_abnormal_inner_ear | 0.50764799 |
| 96 | MP0000266_abnormal_heart_morphology | 0.49467122 |
| 97 | MP0002160_abnormal_reproductive_system | 0.49201737 |
| 98 | MP0002572_abnormal_emotion/affect_behav | 0.49167972 |
| 99 | MP0000003_abnormal_adipose_tissue | 0.48521603 |
| 100 | MP0002752_abnormal_somatic_nervous | 0.47130596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 8.19216432 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 8.06814924 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.73953493 |
| 4 | Exercise-induced myalgia (HP:0003738) | 7.33513553 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.40144136 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 5.59157540 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.23667604 |
| 8 | Distal arthrogryposis (HP:0005684) | 5.14500310 |
| 9 | Popliteal pterygium (HP:0009756) | 4.80770198 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 4.32299063 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 4.32069591 |
| 12 | Myopathic facies (HP:0002058) | 4.10555872 |
| 13 | Type 2 muscle fiber atrophy (HP:0003554) | 4.08814436 |
| 14 | Round ear (HP:0100830) | 4.07352404 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.04201267 |
| 16 | Malignant hyperthermia (HP:0002047) | 3.97360359 |
| 17 | Abnormality of the neuromuscular junction (HP:0003398) | 3.87331529 |
| 18 | Fatigable weakness (HP:0003473) | 3.87331529 |
| 19 | EMG: myopathic abnormalities (HP:0003458) | 3.83052857 |
| 20 | Absent phalangeal crease (HP:0006109) | 3.72747624 |
| 21 | Myoglobinuria (HP:0002913) | 3.55448776 |
| 22 | Fetal akinesia sequence (HP:0001989) | 3.54201224 |
| 23 | Muscle fiber atrophy (HP:0100295) | 3.54121639 |
| 24 | Muscle stiffness (HP:0003552) | 3.49779109 |
| 25 | Abnormality of placental membranes (HP:0011409) | 3.40334092 |
| 26 | Amniotic constriction ring (HP:0009775) | 3.40334092 |
| 27 | True hermaphroditism (HP:0010459) | 3.39532182 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 3.32418387 |
| 29 | Molar tooth sign on MRI (HP:0002419) | 3.32418387 |
| 30 | Abnormality of the calf musculature (HP:0001430) | 3.31551709 |
| 31 | Muscle fiber splitting (HP:0003555) | 3.25963111 |
| 32 | Weak cry (HP:0001612) | 3.21703088 |
| 33 | Thin ribs (HP:0000883) | 3.17141069 |
| 34 | Areflexia of lower limbs (HP:0002522) | 3.16654817 |
| 35 | Calcaneovalgus deformity (HP:0001848) | 3.12434052 |
| 36 | Rhabdomyolysis (HP:0003201) | 3.10973602 |
| 37 | Abnormal finger flexion creases (HP:0006143) | 3.06528940 |
| 38 | Gowers sign (HP:0003391) | 2.94807492 |
| 39 | Myotonia (HP:0002486) | 2.93543154 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.92228482 |
| 41 | Duplicated collecting system (HP:0000081) | 2.88982040 |
| 42 | Neck muscle weakness (HP:0000467) | 2.86112344 |
| 43 | Easy fatigability (HP:0003388) | 2.83089187 |
| 44 | Congenital stationary night blindness (HP:0007642) | 2.77569433 |
| 45 | Abnormality of the renal collecting system (HP:0004742) | 2.76725042 |
| 46 | Deformed tarsal bones (HP:0008119) | 2.75675466 |
| 47 | Aplasia of the musculature (HP:0100854) | 2.68092753 |
| 48 | Reticulocytopenia (HP:0001896) | 2.61857097 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.60895994 |
| 50 | Abnormal biliary tract physiology (HP:0012439) | 2.59496579 |
| 51 | Bile duct proliferation (HP:0001408) | 2.59496579 |
| 52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.54364936 |
| 53 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.51627872 |
| 54 | Bifid tongue (HP:0010297) | 2.40880021 |
| 55 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.39718083 |
| 56 | Pancreatic fibrosis (HP:0100732) | 2.38656144 |
| 57 | Global brain atrophy (HP:0002283) | 2.33517032 |
| 58 | Vacuolated lymphocytes (HP:0001922) | 2.28441377 |
| 59 | Hypoplastic ischia (HP:0003175) | 2.27320756 |
| 60 | Hemiparesis (HP:0001269) | 2.25805862 |
| 61 | Pancreatic cysts (HP:0001737) | 2.25289389 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.14697072 |
| 63 | Subaortic stenosis (HP:0001682) | 2.14697072 |
| 64 | Bulbar palsy (HP:0001283) | 2.11784983 |
| 65 | Difficulty running (HP:0009046) | 2.10838630 |
| 66 | Generalized muscle weakness (HP:0003324) | 2.09727331 |
| 67 | Rimmed vacuoles (HP:0003805) | 2.09690500 |
| 68 | Abnormality of the ischium (HP:0003174) | 2.09623598 |
| 69 | Long clavicles (HP:0000890) | 2.09583215 |
| 70 | Febrile seizures (HP:0002373) | 2.07426861 |
| 71 | Sudden death (HP:0001699) | 2.04098914 |
| 72 | Abnormality of the calcaneus (HP:0008364) | 2.03765620 |
| 73 | Nonprogressive disorder (HP:0003680) | 2.02004650 |
| 74 | Impaired smooth pursuit (HP:0007772) | 2.00134466 |
| 75 | Chromsome breakage (HP:0040012) | 1.98503152 |
| 76 | Dilated cardiomyopathy (HP:0001644) | 1.96706416 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 1.96648796 |
| 78 | Bundle branch block (HP:0011710) | 1.95363558 |
| 79 | Nephronophthisis (HP:0000090) | 1.93593638 |
| 80 | Hypoplastic iliac wings (HP:0002866) | 1.93158878 |
| 81 | Abnormality of DNA repair (HP:0003254) | 1.90018154 |
| 82 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.86403253 |
| 83 | Pterygium (HP:0001059) | 1.84917935 |
| 84 | Frequent falls (HP:0002359) | 1.82134986 |
| 85 | Epiphyseal dysplasia (HP:0002656) | 1.81042962 |
| 86 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.76209797 |
| 87 | Infantile muscular hypotonia (HP:0008947) | 1.75550998 |
| 88 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.74156720 |
| 89 | Abnormal pupillary function (HP:0007686) | 1.73588981 |
| 90 | Lipoatrophy (HP:0100578) | 1.73206284 |
| 91 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.72844499 |
| 92 | Failure to thrive in infancy (HP:0001531) | 1.72325911 |
| 93 | EMG: neuropathic changes (HP:0003445) | 1.71648161 |
| 94 | Limb dystonia (HP:0002451) | 1.70889389 |
| 95 | Hip contracture (HP:0003273) | 1.70842627 |
| 96 | Cystic hygroma (HP:0000476) | 1.69962993 |
| 97 | Truncal obesity (HP:0001956) | 1.68562963 |
| 98 | Cystic liver disease (HP:0006706) | 1.67628631 |
| 99 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.67342466 |
| 100 | Akinesia (HP:0002304) | 1.66476324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.36249960 |
| 2 | MUSK | 5.41838346 |
| 3 | GRK1 | 4.70546617 |
| 4 | PHKG2 | 4.62716236 |
| 5 | PHKG1 | 4.62716236 |
| 6 | IRAK1 | 3.74899831 |
| 7 | ADRBK2 | 3.21929809 |
| 8 | TSSK6 | 2.90223991 |
| 9 | TTN | 2.53703401 |
| 10 | PIK3CG | 2.34257888 |
| 11 | FRK | 2.25175728 |
| 12 | MAP4K2 | 2.20146132 |
| 13 | DAPK2 | 1.93285633 |
| 14 | FGFR3 | 1.80679553 |
| 15 | WEE1 | 1.73990239 |
| 16 | MAPK12 | 1.69115859 |
| 17 | PRKD3 | 1.68401397 |
| 18 | MAPKAPK3 | 1.42158884 |
| 19 | LIMK1 | 1.40739397 |
| 20 | MAP2K3 | 1.36546842 |
| 21 | MAPKAPK5 | 1.35351359 |
| 22 | RPS6KB2 | 1.27054096 |
| 23 | MAPK15 | 1.23889090 |
| 24 | NTRK3 | 1.20475677 |
| 25 | PNCK | 1.20248396 |
| 26 | PTK2B | 1.15395807 |
| 27 | ERBB3 | 1.13940745 |
| 28 | TRPM7 | 1.09192516 |
| 29 | TIE1 | 1.05333116 |
| 30 | MAP3K2 | 1.01756699 |
| 31 | ADRBK1 | 1.00972597 |
| 32 | SCYL2 | 0.99910005 |
| 33 | CASK | 0.94935047 |
| 34 | DYRK1A | 0.93779842 |
| 35 | NME1 | 0.93043720 |
| 36 | MAP3K4 | 0.89904889 |
| 37 | NUAK1 | 0.85075133 |
| 38 | PINK1 | 0.82318092 |
| 39 | MAPK7 | 0.73948524 |
| 40 | AKT2 | 0.73874778 |
| 41 | MAPK13 | 0.73517676 |
| 42 | LATS2 | 0.73292735 |
| 43 | VRK2 | 0.69704542 |
| 44 | DDR2 | 0.67581606 |
| 45 | TBK1 | 0.64578294 |
| 46 | ROCK1 | 0.61119195 |
| 47 | EEF2K | 0.59106950 |
| 48 | DYRK3 | 0.58732161 |
| 49 | MAP3K1 | 0.56189753 |
| 50 | MARK1 | 0.55485196 |
| 51 | EIF2AK2 | 0.54004393 |
| 52 | PRKAA1 | 0.52421818 |
| 53 | FGFR2 | 0.50496308 |
| 54 | EIF2AK3 | 0.49344298 |
| 55 | VRK1 | 0.48923707 |
| 56 | MAP2K6 | 0.48613461 |
| 57 | PRKAA2 | 0.47489686 |
| 58 | PRKD2 | 0.47413570 |
| 59 | PRKG1 | 0.47296968 |
| 60 | MAP2K4 | 0.42670948 |
| 61 | PRKACB | 0.40400591 |
| 62 | STK39 | 0.39149849 |
| 63 | PRKACA | 0.38326807 |
| 64 | CAMK2A | 0.37851770 |
| 65 | MOS | 0.37388314 |
| 66 | CAMK2D | 0.37096501 |
| 67 | GRK5 | 0.36361293 |
| 68 | NEK2 | 0.35677780 |
| 69 | CDK3 | 0.33543828 |
| 70 | RPS6KB1 | 0.32357836 |
| 71 | TAOK1 | 0.30627900 |
| 72 | MAP2K1 | 0.30327123 |
| 73 | RAF1 | 0.29717193 |
| 74 | MELK | 0.28277114 |
| 75 | KSR2 | 0.27932598 |
| 76 | PRKCG | 0.27458669 |
| 77 | PRKACG | 0.25393299 |
| 78 | STK3 | 0.25276860 |
| 79 | BRSK2 | 0.25249404 |
| 80 | PRKCE | 0.24138708 |
| 81 | ROCK2 | 0.23967944 |
| 82 | OXSR1 | 0.21588209 |
| 83 | MAPK4 | 0.20686441 |
| 84 | SGK1 | 0.20142881 |
| 85 | MKNK2 | 0.19678164 |
| 86 | TAOK2 | 0.19676404 |
| 87 | CAMK2G | 0.19615212 |
| 88 | CAMK2B | 0.18341386 |
| 89 | CSNK1A1 | 0.17600644 |
| 90 | TESK2 | 0.16578287 |
| 91 | MAP3K7 | 0.16097842 |
| 92 | TNIK | 0.14492341 |
| 93 | RPS6KA3 | 0.14276126 |
| 94 | PRKD1 | 0.13133514 |
| 95 | INSRR | 0.13118764 |
| 96 | PLK3 | 0.12947279 |
| 97 | FGFR1 | 0.12699096 |
| 98 | INSR | 0.12007466 |
| 99 | CAMKK2 | 0.11592548 |
| 100 | CCNB1 | 0.11191655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.65423151 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.30192874 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.98311667 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.91670213 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.89171937 |
| 6 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.80061840 |
| 7 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.52126419 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28925012 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.08640655 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92705277 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.85027691 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.83792332 |
| 13 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.75987337 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.75832006 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.65878629 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.64767076 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.63688536 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60122585 |
| 19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.50541939 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.49263391 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43523799 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.42641228 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.35966917 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.35711032 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34571275 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.32541269 |
| 27 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.32179266 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.30551301 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.27377316 |
| 30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.24750891 |
| 31 | Circadian entrainment_Homo sapiens_hsa04713 | 1.23143951 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.21839157 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21223679 |
| 34 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.18144073 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16486455 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.13379549 |
| 37 | GABAergic synapse_Homo sapiens_hsa04727 | 1.07293623 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04844570 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04563454 |
| 40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03963847 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03810076 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.03596111 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03164469 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03034785 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99764588 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99724523 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97740857 |
| 48 | Tight junction_Homo sapiens_hsa04530 | 0.97411877 |
| 49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.92863542 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91923605 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91913045 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 0.91454023 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90368958 |
| 54 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87100428 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86023991 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85295450 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85255881 |
| 58 | RNA degradation_Homo sapiens_hsa03018 | 0.84645862 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77834014 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77250608 |
| 61 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76804916 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74707154 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.70169951 |
| 64 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69651988 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 0.69416533 |
| 66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68190953 |
| 67 | Peroxisome_Homo sapiens_hsa04146 | 0.67740761 |
| 68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67527576 |
| 69 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66400094 |
| 70 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.65988211 |
| 71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.65475989 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65217833 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.65060673 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.64955131 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.63522475 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62550194 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61488368 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.61346530 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60144697 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59919116 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.59171802 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59169538 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58281249 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.58120898 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57816152 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54371999 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52267668 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.49931895 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48727077 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.47724599 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46381245 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45269246 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.45061491 |
| 94 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44648082 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43310423 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40772877 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40160174 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39908186 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39192265 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37298054 |

